| Literature DB >> 35378660 |
Martin L Skogar1, Erik Stenberg2, Magnus Sundbom3.
Abstract
PURPOSE: Major abdominal surgery carried out in the later part of the week has been associated with increased complication rates. The aim of this study was to explore whether the weekday of surgery affects the 30-day complication risks after primary Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG).Entities:
Keywords: Bariatric surgery; Roux-en-Y gastric bypass (RYGB); Sleeve gastrectomy (SG); Weekday
Mesh:
Year: 2022 PMID: 35378660 PMCID: PMC9072493 DOI: 10.1007/s11695-022-06041-9
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 3.479
Characteristics by weekday of the 49,349 patients included in the study cohort
| Monday (%) | Tuesday (%) | Wednesday (%) | Thursday (%) | Friday (%) | Unadjusted | ||
|---|---|---|---|---|---|---|---|
| Total number of procedures | 15,100 | 14,055 | 12,033 | 7148 | 1013 | ||
| Operation | LRYGB | 86.5% | 82.7% | 90.3% | 88.7% | 89.3% | < 0.01 |
| LSG | 13.5% | 17.3% | 9.7% | 11.3% | 10.7% | ||
| Gender | Female | 75.5% | 77.0% | 76.5% | 76.6% | 78.0% | 0.03 |
| Male | 24.5% | 23.0% | 23.5% | 23.4% | 22.0% | ||
| Age (year) | < 30 | 20.5% | 19.9% | 21.1% | 21.7% | 18.6% | < 0.01 |
| 30–40 | 26.4% | 27.4% | 27.5% | 26.7% | 28.6% | ||
| 40–50 | 30.8% | 31.2% | 30.8% | 29.7% | 31.7% | ||
| 50–60 | 18.8% | 18.2% | 17.7% | 18.3% | 18.3% | ||
| > 60 | 3.5% | 3.3% | 2.9% | 3.6% | 2.9% | ||
| BMI (kg/m2) | < 40 | 40.8% | 43.5% | 38.7% | 42.4% | 44.6% | < 0.01 |
| 40–50 | 50.4% | 49.6% | 54.2% | 51.2% | 50.4% | ||
| 50–60 | 7.8% | 6.2% | 6.5% | 5.8% | 4.9% | ||
| > 60 | 1.0% | 0.7% | 0.6% | 0.5% | 0.0% | ||
| Year of surgery | 2010 | 13.5% | 13.7% | 13.9% | 12.4% | 19.2% | < 0.01 |
| 2011 | 15.1% | 14.8% | 17.2% | 14.7% | 26.0% | ||
| 2012 | 15.1% | 13.4% | 15.1% | 13.5% | 16.7% | ||
| 2013 | 15.3% | 14.3% | 15.0% | 13.5% | 16.3% | ||
| 2014 | 13.8% | 13.1% | 12.3% | 13.9% | 10.8% | ||
| 2015 | 12.2% | 12.2% | 11.5% | 13.7% | 5.6% | ||
| 2016 | 10.0% | 12.1% | 9.5% | 12.4% | 4.5% | ||
| 2017 | 4.9% | 6.3% | 5.5% | 6.0% | 0.9% | ||
| Smoking | Yes | 10.4% | 11.5% | 10.7% | 11.9% | 11.2% | < 0.01 |
| Missing data | 32.4% | 28.1% | 32.1% | 27.5% | 38.6% | ||
| Diabetes* | 14.2% | 13.0% | 13.5% | 13.5% | 11.0% | < 0.01 | |
| Sleep apnea* | 10.2% | 9.6% | 9.9% | 9.6% | 8.1% | 0.14 | |
| Hypertension* | 25.9% | 24.4% | 25.2% | 25.1% | 22.8% | 0.02 | |
| Depression* | 15.5% | 15.2% | 15.3% | 15.5% | 15.3% | 0.92 | |
| Acid-related conditions* | 9.6% | 10.2% | 9.9% | 11.3% | 7.7% | < 0.01 | |
| History of DVT | 2.5% | 2.5% | 2.4% | 2.2% | 3.1% | 0.31 | |
BMI body mass index, DVT deep vein thrombosis, LRYGB laparoscopic Roux-en-Y gastric bypass, LSG laparoscopic sleeve gastrectomy
*Defined by ongoing medication (use of continuous positive airway pressure, CPAP for sleep apnea)
Complications and adverse events by weekday
| Monday | Tuesday | Wednesday | Thursday | Friday | Unadjusted | ||
|---|---|---|---|---|---|---|---|
| Total number of procedures | 15,100 | 14,055 | 12,033 | 7148 | 1013 | ||
| Severe complications* | 417 (2.8) | 368 (2.6) | 394 (3.3) | 217 (3.0) | 32 (3.2) | 0.02 | |
| Unadjusted (OR) | Ref | 0.95 (0.82–1.09) | 1.19 (1.04–1.37) | 1.10 (0.93–1.30) | 1.15 (0.80–1.66) | ||
| Adjusted (OR) | Ref | 0.95 (0.81–1.11) | 1.10 (0.94–1.28) | 1.00 (0.83–1.19) | 0.92 (0.62–1.36) | ||
| Overall complications | 1085 (7.2) | 942 (6.7) | 922 (7.7) | 551 (7.7) | 74 (7.3) | 0.02 | |
| Unadjusted (OR) | Ref | 0.93 (0.85–1.02) | 1.07 (0.98–1.17) | 1.08 (0.97–1.20) | 1.02 (0.80–1.30) | ||
| Adjusted (OR) | Ref | 0.91 (0.83–1.01) | 1.09 (0.98–1.20) | 0.97 (0.86–1.08) | 0.91 (0.70–1.18) | ||
| Readmission | 1102 (7.3) | 1047 (7.4) | 923 (7.7) | 568 (7.9) | 86 (8.5) | 0.32 | |
| Unadjusted (OR) | Ref | 1.02 (0.94–1.12) | 1.06 (0.96–1.15) | 1.10 (0.99–1.22) | 1.18 (0.94–1.48) | ||
| Adjusted (OR) | Ref | 0.86 (0.78–0.95) | 0.95 (0.86–1.05) | 0.96 (0.85–1.08) | 0.99 (0.77–1.27) | ||
| Specific complications ( | Leak | 127 (0.8) | 113 (0.8) | 115 (1.0) | 71 (1.0) | 10 (1.0) | 0.53 |
| Abscess | 102 (0.7) | 77 (0.5) | 88 (0.7) | 57 (0.8) | 5 (0.5) | 0.19 | |
| Bleeding | 257 (1.7) | 219 (1.6) | 222 (1.8) | 128 (1.8) | 14 (1.4) | 0.38 | |
| Bowel obstruction | 145 (1.0) | 127 (0.9) | 150 (1.2) | 56 (0.8) | 9 (0.9) | 0.01 | |
| Cardiovascular event | 21 (0.1) | 22 (0.2) | 9 (0.1) | 10 (0.1) | 4 (0.4) | 0.06 | |
| DVT/PE | 14 (0.1) | 11 (0.1) | 9 (0.1) | 8 (0.1) | 0 (0) | 0.77 | |
| Pulmonary complication | 63 (0.4) | 80 (0.6) | 67 (0.6) | 44 (0.6) | 5 (0.5) | 0.26 | |
DVT/PE deep vein thrombosis/pulmonary embolism
*Defined by complications graded as Clavien-Dindo IIIb or worse, i.e., a complication requiring intervention under general anesthesia, treatment at an intensive care unit, or death